Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for Zenas BioPharma (ZBIO) over the last 2 years, with Q3 2025 value amounting to $2.7 million.

  • Zenas BioPharma's Gains from Investment Securities fell 5751.08% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 5751.08%. This contributed to the annual value of $1.1 million for FY2024, which is 100000.0% up from last year.
  • Per Zenas BioPharma's latest filing, its Gains from Investment Securities stood at $2.7 million for Q3 2025, which was down 5751.08% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, Zenas BioPharma's Gains from Investment Securities peaked at $6.4 million during Q3 2024, and registered a low of $445000.0 during Q1 2025.